Skip to main content

Rare disease gene

Rare disease gene association discovery in the 100,000 Genomes Project


Up to 80% of rare disease patients remain undiagnosed after genomic sequencing1, with many probably involving pathogenic variants in yet to be discovered disease–gene associations. To search for such associations, we developed a rare variant gene burden analytical framework for Mendelian diseases, and applied it to protein-coding variants from whole-genome sequencing of 34,851 cases and their family members recruited to the 100,000 Genomes Project2. A total of 141 new associations were identified, including five for which independent disease–gene evidence was recently published. Following in silico triaging and clinical expert review, 69 associations were prioritized, of which 30 could be linked to existing experimental evidence.

The five associations with strongest overall genetic and experimental evidence were monogenic diabetes with the known β cell regulator3,4 UNC13A, schizophrenia with GPR17, epilepsy with RBFOX3, Charcot–Marie–Tooth disease with ARPC3 and anterior segment ocular abnormalities with POMK. Further confirmation of these and other associations could lead to numerous diagnoses, highlighting the clinical impact of large-scale statistical approaches to rare disease–gene association discovery.

Rare diseases collectively affect 3.5% to 5.9% of people worldwide5. Despite advances in genomic sequencing, molecular diagnosis continues to elude 50% to 80% of patients presenting to genetic clinics1. Furthermore, fewer than half of the 10,000 rare Mendelian diseases in the Online Mendelian Inheritance in Man (OMIM) database6 have an established genetic basis. Diagnostic failure may arise because of a lack of routine screening for non-coding7 or structural variants1. However, it is likely that a substantial proportion of the pathogenic variants responsible for patients undiagnosed with rare disease (cases) reside in those yet to be discovered genes associated with (possibly very rare) disorders.

The scale of rare disease sequencing studies, such as the Undiagnosed Disease Network8, Centers for Mendelian Genomics9, Deciphering Developmental Disorders10 and the 100,000 Genomes Project (100KGP)2, offers expanded opportunities to provide insight into pathogenic mechanisms of inherited disease, including the possibility of establishing disease–gene associations through case–control analyses, akin to methods used previously to identify common genetic variants influencing the risk of complex disorders. Such an approach provides much-needed power to identify genes harbouring rare pathogenic variants.

genetics awards, genomics, DNA research, hereditary science, gene editing, CRISPR recognition, genetic breakthroughs, medical genetics, population genetics, biotechnology awards, Nobel Prize in Genetics, genomic medicine, genetic innovation, molecular biology, personalized medicine, genetics research grants, bioinformatics, evolutionary genetics, genetic engineering, scientific excellence

#GeneticsAwards #Genomics #DNAResearch #HereditaryScience #GeneEditing #CRISPRRecognition #GeneticBreakthroughs #MedicalGenetics #PopulationGenetics #BiotechAwards #NobelPrizeGenetics #GenomicMedicine #GeneticInnovation #MolecularBiology #PersonalizedMedicine #GeneticsResearch #Bioinformatics #EvolutionaryGenetics #GeneticEngineering #ScientificExcellence

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more